Conference Coverage
Videos
NewsNetwork
OncLive® TV
Peer Exchange
Insights
Attend An Event
State of the Science Summit
Regional Seminar Series
OncLive Global Expo
Giants of Cancer Care
OncLive Community
SPECIALTY TOPICS
CURRENTLY VIEWING
All Specialties
Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Precision Medicine in Oncology®
Neoadjuvant HER2+
More >>
<< View all publications

OncologyLive

Investigators Seek to Boost Surgical Cures in RCC With Immune Priming
Investigators Seek to Boost Surgical Cures in RCC With Immune Priming
Vol. 20/No. 14   >   Features
NTRK Gene Fusions: Finding the
NTRK Gene Fusions: Finding the "Golden Ticket" in Oncology
Vol. 20/No. 14   >   Features
CMS Unveils Proposed Radiation Oncology Model of Care
CMS Unveils Proposed Radiation Oncology Model of Care
Vol. 20/No. 14   >   Features
Triplet Targeted Therapy May Signal a New Standard in Metastatic CRC
Triplet Targeted Therapy May Signal a New Standard in Metastatic CRC
Vol. 20/No. 14   >   Pathways
New Data Change Management of Frontline Metastatic Renal Cell Carcinoma
New Data Change Management of Frontline Metastatic Renal Cell Carcinoma
Vol. 20/No. 14   >   Partner Perspective
Fresh Approaches to RT Improve Outcomes in Retroperitoneal Sarcoma
Fresh Approaches to RT Improve Outcomes in Retroperitoneal Sarcoma
Vol. 20/No. 14   >   Partner Perspective
Open-Access Publishing Model May Introduce New Biases in Oncology
Open-Access Publishing Model May Introduce New Biases in Oncology
Vol. 20/No. 14   >   From the Editor
Trial of Triplet Regimen With Cabozantinib Plus Immunotherapy Is Planned in RCC
Trial of Triplet Regimen With Cabozantinib Plus Immunotherapy Is Planned in RCC
Vol. 20/No. 13   >   Features
Therapeutic Utility of Germline Variants Is an
Therapeutic Utility of Germline Variants Is an "Open Question"
Vol. 20/No. 13   >   Pathways
Higher Anthracycline Doses Linked to Breast Malignancy Risk in Childhood Cancer Survivors
Higher Anthracycline Doses Linked to Breast Malignancy Risk in Childhood Cancer Survivors
Vol. 20/No. 13   >   Features
Next Page >>
Publication Bottom Border
Border Publication
 
x